Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Similar documents
11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

Essentials of Clinical MR, 2 nd edition. 65. Benign Hepatic Masses

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Armed Forces Institute of Pathology.

A215- Urinary bladder cancer tissues

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin.

Localized at a focus, central point or locus. Localized finding distinct from neighboring tissues, not a threedimensional

Imaging in gastric cancer

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS

Improved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template

Imaging Ejaculatory Disorders and Hematospermia

OASIS 1.2T: MULTIPARAMETRIC MRI OF PROSTATE CANCER

Diffusion Weighted Imaging in Prostate Cancer


Interesting Cases from Liver Tumor Board. Jeffrey C. Weinreb, M.D.,FACR Yale University School of Medicine

بسم هللا الرحمن الرحيم. Prof soha Talaat

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

Prostate MRI: Not So Difficult. Neil M. Rofsky, MD, FACR, FSCBTMR, FISMRM Dallas, TX

Contrast-enhanced Breast MRI RSSA 2013

MRI BI-RADS: How to make it out?

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Carcinoma of the Urinary Bladder Histopathology

Prostate Cancer Imaging: most common pitfalls in multiparametric Magnetic Resonance

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

ADRENAL MR: PEARLS AND PITFALLS

IMAGING GUIDELINES - COLORECTAL CANCER

Multiparametric MRI diagnostic value in a case of prostate cancer

PI-RADS V2 IN PRACTICE A PICTORIAL REVIEW

SEER Summary Stage Still Here!

First Clinical Experiences with Simultaneous Multi-Slice Accelerated Diffusion-Weighted Imaging Throughout the Body

STAGING AND FOLLOW-UP STRATEGIES

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

AB MR Interpretation Overview

Prostate MRI: Who needs it?

ABDOMINAL DIFFUSION WEIGHTED MR

KEYWORDS Bladder cancer, Transitional cell carcinoma, Magnetic resonance imaging, staging, Tumor node metastasis

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Prostate Case Scenario 1

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

JMSCR Vol 05 Issue 06 Page June 2017

FieldStrength. Multi-parametric 3.0T MRI provides excellent prostate imaging

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

The pathology of bladder cancer

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

Staging and Grading Last Updated Friday, 14 November 2008

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

A schematic of the rectal probe in contact with the prostate is show in this diagram.

T2, T2*, ute. Yeo Ju Kim. Radiology, Inha University Hospital, Incheon, Korea

Genitourinary Radiology In-Training Test Questions for Diagnostic Radiology Residents

Definition Prostate cancer

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Utility of Prostate MRI. John R. Leyendecker, MD

Index. C Calcifications fat necrosis 1, 61 fat necrosis 4, 69 nipple/peri-areolar involvement 1, 165

Malignant Focal Liver Lesions

Case 9087 Retropharyngeal nodular fasciitis

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Note: The cause of testicular neoplasms remains unknown

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

MRI OF TESTICULAR MALIGNANCIES

Ultrasound of malignant testicular lesions. Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby

Staging Colorectal Cancer

MR Imaging of Prostate Cancer: Present Limitations and Future Directions

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

Prostate Cancer Imaging :What the Urologist Needs to Know

Magnetic Resonance Imaging in the management of prostate cancer: What the Radiologists need to know?

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Magnetic resonance imaging predictors of extracapsular extension of prostate cancer: Do they accurately reflect pt3 staging?

Abdominal applications of DWI

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Current staging of endometrial carcinoma with MR imaging

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Disorders of Cell Growth & Neoplasia. Histopathology Lab

Successful Breast MRI Program : The ingredients

Clinical Applications

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer

Prostate biopsy: MR imaging to the rescue

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Pitfalls in Interpreting mp-mri of the Prostate: A Pictorial Review with Pathologic Correlation

Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

BI-RADS and Breast MRI. Kathy Borovicka, M.D. Thursday February 15, 2018

Leonard M. Glassman MD

PI-RADS classification: prognostic value for prostate cancer grading

COLORECTAL CANCER STAGING in 2010

Excretory urography (EU) or IVP US CT & radionuclide imaging

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Transcription:

73. Urinary Bladder and Male Pelvis Urinary bladder carcinoma is best locally staged with MRI. It is important however to note that a thickened wall (> 5 mm) is a non-specific finding seen in an underfilled bladder, acute cystitis, fibrosis, and infiltrative cancer. Pelvic and perivesical lymph nodes with > 5 mm short axis, with irregular borders and absent fatty hilum are suspicious for lymph node metastases. A large urinary bladder carcinoma is well visualized in Fig. 73.1 on (A) DWI and (B) contrast enhanced FS T1WI, with high SI on DWI (corresponding to restricted diffusion on the ADC map, not shown) and enhancement post-contrast. The moderate degree of enhancement of the bulk of the tumor (when compared to the normal bladder wall) is due to the necrotic nature of the lesion. The inset T2WI demonstrates well the extravesical tumor in perivesical fat. The abdominal wall is not invaded, thus by TNM classification this is a T3b lesion. The pre-ostial segment of the right ureter is also noted to be enlarged. Fig. 73.1 A reduced field of view has been shown to improve image quality and may have the potential to improve the accuracy of differentiating between muscle invasive and nonmuscle invasive urinary bladder cancer. Carcinoma enhances earlier and more avidly than the normal wall. Delayed (> 2 minutes) post-contrast image acquisition limits evaluation of

the bladder wall due to urinary excretion of the administered gadolinium chelate. Cystitis enhances similarly, as opposed to the late enhancement seen with wall fibrosis. Bladder carcinoma is staged by the TNM system based on whether the tumor is superficial to the muscular layer (T1), invades the layer superficially (T2a) or deeply (T2b), invades the perivesicular fat micro- (T3a) or macroscopically (T3b), or extends to adjacent organs (T4). An intact low SI muscular layer signifies a T1-T2 lesion on MR, whereas T2b and T3a lesions cannot be readily distinguished on MR. Fig. 73.2 A small TNM T2 bladder carcinoma is shown in Fig. 73.2 on T2WI, located along the right urinary bladder wall. This was seen on an exam performed for the prostate. The inset DWI image demonstrates the high SI of the lesion, which corresponded to restricted diffusion on the ADC map (not shown). Nodal evaluation by MR is guided by size (abnormal being defined as > 10 mm for oval and > 8 mm for round nodes) with accuracy comparable to CT. Staging is based on node number and location, with a single regional lymph node metastasis in the true pelvis defining N1, multiple such defining N2 and metastasis to the common iliac lymph nodes defining N3. Detection of distant metastases to bone (M1) is best identified, due to the high SI of the metastasis, on FS or STIR T2WI. The seminal vesicles are posterosuperior to the prostate, exhibiting loss of their normal hyperintense fluid SI on T2WI if involved with cancer. Seminal vesicle cysts, associated with urogenital abnormalities, are the most common congenital abnormality of the seminal vesicles. MR plays an evolving role in preoperative staging of prostate cancer and in assessing therapeutic response. At 1.5 T high resolution imaging necessitates use of an endorectal coil (for adequate SNR). The disadvantage of an endorectal coil (which regardless of field strength improves SNR and image quality) is that it can be uncomfortable. The need for an endorectal coil at 3 T is controversial, with prostate MR performed at many sites without such (employing only a pelvic phased-array coil). The normal prostate appears homogeneous on T1WI, the majority of the gland (i.e. the peripheral 60%) appearing

73.3 hyperintense on T2WI. Hyperintensity on T2WI correlates with predominance of fluidfilled acinar elements peripherally as opposed to smooth muscle elements in transitional and periurethral regions. Figure 73.3 A, B illustrates a case of benign prostate hypertrophy, showing a symmetrically enlarged prostate on (A) axial T2WI with nodular enlargement of the central gland. On (B) CE T1WI such regions are hypointense to the otherwise heterogeneously enhancing gland. In distinction, prostate carcinoma may manifest as a hypointense lesion in the gland s periphery on T2WI, although this guideline is less reliable for the detection of higher SI mucinous tumors. The finding of capsular and neurovascular bundle invasion is important for staging purposes and for tailoring surgical treatment. Figure 73.3 illustrates on (C) FS T2WI and (D) CE FS T1WI a case of prostate carcinoma clearly invading the capsule (white arrow) and extending to the right pelvic side wall. A useful finding denoting extracapsular extension, illustrated in this case, is loss of the normal recto prostate angle a normal angle denoted by the asterisk in Fig. 73.3A. Other suggestive findings on T2WI include an irregular bulge of tissue beyond the low SI capsule, smooth capsular bulges, and neurovascular bundle asymmetry. Periurethral or transitional zone neoplasms are difficult to identify on T2WI. Furthermore, the classic finding of peripheral cancer on conventional MR a hypointense peripheral lesion is nonspecific for prostate cancer, occurring also with hemorrhage, prostatitis, and prostate atrophy or fibrosis. A number of MR techniques may be combined to more accurately identify prostate cancer. DWI is useful both in initial detection of neoplasm and in assessing tumor recurrence post-operatively. Increased cellularity of prostatic neoplasia restricts the extent

of Brownian water (proton) motion in the extracellular space, a condition manifest as high SI and low ADC values on DWI. Whole body DWI may eventually play a role in detecting distant prostatic metastases. MR spectroscopy findings of prostate cancer include increased choline + creatine to citrate ratios, although such alterations may also be seen with prostatitis or focal atrophy. Dynamic contrast enhanced MRI commonly used in breast imaging (see Chapter 63) can be utilized to construct pharmacokinetic models of tissue gadolinium concentration, although semi-quantitative approaches have been shown to be equally effective in identifying prostate malignancy. Enhancement patterns consistent with neoplasia include early enhancement onset, short time to peak, high levels of peak enhancement, and early washout of enhancement. The most discriminating parameter is derived from subtraction of peak enhancement values in the region of concern from that of adjacent peripheral or central glandular tissue, termed relative peak enhancement. A high relative peak enhancement is characteristic of prostate carcinoma. Compressed sensing has made this approach more viable, with resultant high temporal resolution and image quality. Illustrated in fig. 73.4 are GRASP scans (selected time points pre- and post-contrast) acquired at 3 T with a 2.2 sec temporal and a 1.1 mm spatial resolution. A suspicious lesion (arrow) in the peripheral zone with early enhancement and rapid washout is identified. Courtesy of Kai Tobias Block Fig. 73.4 Scrotal abnormalities are not uncommonly evaluated on MR, with positioning important when using a surface coil to assure that side-to-side differences involving the testicles reflect pathology, not simply distance from the coil. The normal testes are intermediate SI between fluid and fat SI on T1WI, slightly hypointense to fluid on T2WI, and covered by a hypointense layer of fibrous tissue the tunica albuginea. Bilateral hydroceles are illustrated in the (A) axial T2, (B) T1, and (C) sagittal T1WI of Fig. 73.5. The testes in these images are not clearly seen, but the hydroceles demonstrate the expected SI of (A) hyperintensity on T2 and (B, C) hypointensity on T1WI. Testicular cysts are a commonly identified, fluid-like SI lesion on MR. MR characteristics of neoplastic testicular masses are dependent on tumor pathology with seminomas exhibiting homogeneous hypointensity on

T2WI possibly with low SI fibrous bands which enhance more than the remainder of the tumor. Nonseminomatous tumors are more heterogeneous both pre- and post-contrast. Acute testicular infarctions, as seen in the setting of torsion, likewise manifest as edemalike SI, with more chronic lesions appearing as low SI scar. Fig. 73.5